Human leukocyte antigen epitope antigenicity and immunogenicity

Current Opinion in Organ Transplantation

Volumn 19, Issue 4, 2014, Pages 428-435

  Duquesnoy, René J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Eplet; HLA epitope; HLAMatchmaker; Human leukocyte antigen antibody; Nonself self paradigm of HLA epitope immunogenicity

Indexed keywords

EPITOPE; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN RECEPTOR; ANTIBODY;

ALLOIMMUNITY; AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN STRUCTURE; ANTIGENICITY; COMPLEMENTARITY DETERMINING REGION; HEAVY CHAIN; HLA SYSTEM; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; LIGHT CHAIN; REVIEW; SYSTEMATIC REVIEW; ANIMAL; ANTIBODY PRODUCTION; CHEMISTRY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; EPITOPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS;

EID: 84904130594     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000100     Document Type: Review

References (35)

1. Duquesnoy RJ. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opinion Immunol 2008; 20:594-601.
2. Duquesnoy RJ, Marrari M. HLAMatchmaker-based definition of structural HLA epitopes detected by alloantibodies. Curr Opin Organ Transplant 2009; 14:403-409.
3. Lutz CT. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells. Curr Opin Organ Transplant 2014; 19:436-441.
4. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Human Immunol 2006; 67:847-862.
5. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ and HLA-DP. Human Immunol 2007; 68:12-25.
6. Duquesnoy RJ, Mostecki J, Hariharan J, Balazs I. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns. Human Immunol 2008; 69:826-832.
7. Duquesnoy RJ. Update of the HLA class I eplet database in the website based registry of antibody-defined HLA epitopes. Tissue Antigens 2014; 3:382-390.
8. Sousa LC, Filho HL, Von Glehn C de Q, et al. EpHLA: an innovative and userfriendly software automating the HLAMatchmaker algorithm for antibody analysis. Transpl Immunol 2011; 25:210-216.
9. Filho HL, da Mata Sousa LC, von Glehn C de Q, et al. EpHLA software: a timesaving and accurate tool for improving identification of acceptable mismatches for clinical purposes. Transpl Immunol 2012; 26:230-234.
10. Duquesnoy RJ, Marrari M, Mulder A, et al. First report on the antibody verification of HLA-ABC epitopes recorded in the HLA epitope registry. Tissue Antigens 2014; 83:391-400.
11. Duquesnoy RJ, Mulder A, Askar M, et al. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005; 66:749-761.
12. Marrari M, Mostecki J, Mulder A, et al. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets. Transplantation 2010; 90:1468-1472.
13. Duquesnoy RJ, Marrari M, Jelenik L, et al. Structural aspects of HLA class I epitopes reacting with humanmonoclonal antibodies in Ig-binding,C1q-binding and lymphocytotoxicity assays. Hum Immunol 2013; I74:1271-1279.
14. Duquesnoy RJ, Marrari M. Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. Transpl Immunol 2011; 24:164-171.
15. Honger G, Fornaro I, Granado C, et al. Frequency and determinants of pregnancy-induced child-specific sensitization. Am J Transplant 2013; 13:746-753.
16. Wiebe C, Pochinco D, Blydt-Hansen TD, et al. Class II HLA epitope matching: a strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant 2013; 13:3114-3122.
17. Kosmoliaptsis V, Bradley JA, Sharples LD, et al. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008; 85:1817-1825.
18. Kosmoliaptsis V, Chaudhry AN, Sharples LD, et al. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2009; 88:791-798.
19. Kosmoliaptsis V, Dafforn TR, Chaudhry AN, et al. High-resolution, threedimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol 2011; 72:1049-1059.
20. Mallon DH, Bradley JA, Taylor CJ, Kosmoliaptsis V. Structural and electrostatic analysis of HLA B-cell epitopes: inference on immunogenicity and prediction of humoral alloresponses. Curr Opin Organ Transplant 2014; 19:420-427.
21. Duquesnoy RJ. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int J Immunogenet 2012; 39:1-9.
22. Burnet FM, Fenner F. The production of antibodies. Melbourne: Macmillan; 1949.
23. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 125:373-389.
24. Janeway CAJ Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992; 13:11-16.
25. Tauber AI. The immune self: theory or metaphor?. Cambridge, UK: Cambridge Univ Press; 1994.
26. Pradeu T, Carosella ED. On the definition of a criterion of immunogenicity. Proc Natl Acad Sci USA 2006; 103:17858-17861.
27. Cohn M, Mitchison NA, Paul WE, et al. Reflections on the clonal-selection theory. Nat Rev Immunol 2007; 7:823-830.
28. Duquesnoy RJ. Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity. Front Immunol 2011; 2:59.
29. Marrari M, Conca R, Praticò-Barbato L, et al. Brief report: why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? Transpl Immunol 2011; 25:217-220.
30. Claas FH, Witvliet MD, Duquesnoy RJ, et al. The acceptable mismatch program as a fast tool to transplant highly sensitized patients awaiting a post-mortal kidney: short waiting time and excellent graft outcome. Transplantation 2004; 78:190-193.
31. Duquesnoy RJ, Marrari M, da M Sousa LC, et al. 16th IHIW: a website for the antibody-defined HLA epitope registry. Int J Immunogenet 2013; 40:54-59.
32. El-Awar NR, Akaza T, Terasaki PI, Nguyen A. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007; 84:532-540.
33. El-Awar NR, Terasaki PI, Nguyen A, et al. New HLA class I epitopes defined by murine monoclonal antibodies. Hum Immunol 2010; 71:456-461.
34. Duquesnoy RJ, Marrari M, Tambur A, et al. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA epitope registry. Hum Immunol 2014. (in press).
35. Duquesnoy RJ, Marrari M, Mostecki J, et al. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry. Int J Immunogenet 2014. (in press).